MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.605
-0.025 (-1.53%)
Dec 2, 2025, 11:05 AM EST - Market open
MaxCyte Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$7.50
Upside
+367.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $6 | Buy | Initiates | $6 | +273.83% | Jul 22, 2025 |
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +460.75% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +585.36% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +585.36% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +398.44% | Mar 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +336.14% | Nov 29, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +647.66% | Oct 5, 2023 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | +647.66% | Mar 28, 2023 |
| BTIG | BTIG | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +585.36% | Aug 15, 2022 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $19 | Buy | Initiates | $19 | +1,083.80% | Aug 24, 2021 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 24, 2021 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 24, 2021 |
| Stifel | Stifel | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +1,021.50% | Aug 24, 2021 |
| BTIG | BTIG | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +1,270.72% | Aug 24, 2021 |